Showing posts with label Thomas and Betts. Show all posts
Showing posts with label Thomas and Betts. Show all posts

Wednesday, August 10, 2011

DSW (DSW) (TNB) (NBIX) (FSL) (MITT) Get New Coverage

DSW Inc. (NYSE: DSW), Thomas & Betts Co. (NYSE: TNB), Neurocrine Biosciences Inc. (NASDAQ: NBIX), Freescale Semi (NYSE: FSL) and AG Mortgage Investment Trust (NASDAQ: MITT) getting new analyst coverage.

Macquarie initiated coverage on Thomas & Betts Co. (TNB). They placed a “Neutral” rating on the company.

Avondale Partners initiated coverage on DSW Inc. (DSW). They placed an “Outperform” rating and a price target of $50.00 on the company.

MKM Partners initiated coverage on Neurocrine Biosciences Inc. (NBIX). They placed a “Buy” rating and a price target of $12.00 on the company.

Gleacher & Co. initiated coverage on Freescale Semi (FSL). The y placed a “Buy” rating on the company.

Stifel Nicolaus initiated coverage on AG Mortgage Investment Trust (MITT). They placed a “Buy” rating and a price target of $22.00 on the company.

Wednesday, May 11, 2011

Ratings on (SCGLY) (SYK) (TNB) (VTR) Upgraded

Ratings on shares of Societe Generale SA (NASDAQ: SCGLY), Stryker (NYSE: SYK), Thomas & Betts Co. (NYSE: TNB) and Ventas (NYSE: VTR) were upgraded by analysts.

RBS upgraded Societe Generale SA (SCGLY) from a “sell” rating to a “hold” rating.

Goldman Sachs (NYSE:GS) upgraded Stryker (SYK) from a “neutral” rating to a “buy” rating.

Bank of America (NYSE:BAC) upgraded Thomas & Betts Co. (TNB) from a “neutral” rating to a “buy” rating. They have a price target of $68.00 on the company.

Stifel Nicolaus upgraded Ventas (VTR) from a “hold” rating to a “buy” rating. They now have a price target of $60.00 on the company.